English  |  正體中文  |  简体中文  |  Items with full text/Total items : 6024/14565 (41%)
Visitors : 14092549      Online Users : 419
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.fy.edu.tw:8080/ir/handle/987654321/8345


    Title: STAT3 Ser727 Phosphorylation and Its Association with Negative Estrogen Receptor Status in Breast Infiltrating Ductal Carcinoma.
    Authors: Yao-Tsung Yeh;Fu Ou-Yang;I-Fen Chen;Sheau-Fang Yang;Yuan-Yung Wang;Hung-Yi Chuang;Jinu-Huang Su;Ming-Feng Hou;Shyng-Shiou F. Yuan
    Contributors: 輔英科技大學 醫學檢驗生物技術系
    Keywords: breast cancer;infiltrating ductal carcinoma;STAT3;serine phosphorylation;estrogen receptor
    Date: 2006-06-01
    Issue Date: 2010-10-27 10:39:52 (UTC+8)
    Abstract: Although it is known that STAT3 transcriptional activity is modulated by phosphorylation at serine residue 727, the role of STAT3 serine phosphorylation in breast cancer remains mostly unexplored. In this study, we examined the expression patterns of serine residue 727-phosphorylated STAT3 (p-ser727-STAT3) in breast infiltrating ductal carcinoma tissues and nearby noncancer tissues by using immunoblotting techniques, and correlated the expression profiles with clinicopathological characteristics. A significantly elevated p-ser727-STAT3 expression was observed in 61.8% (42/68) of breast cancer tissues as compared to corresponding noncancer tissues (p < 0.001). Further, immunohistochemical analysis also showed an increased nuclear p-ser727-STAT3 staining in cancer lesions. The increased p-ser727-STAT3 expression in breast infiltrating ductal carcinoma tissues correlated significantly with negative estrogen receptor (ER) status, increased stage of cancer and increased tumor size (p = 0.001, 0.024 and 0.014, individually). Intriguingly, we noticed that the expression levels of p-ser727-STAT3 in ER-negative breast cancer cell lines were higher than those in ER-positive breast cancer cell lines. In ER-positive MCF7 cells, treatment with ERalpha-specific siRNA increased, whereas treatment with anticancer drug tamoxifen decreased the expression of p-ser727-STAT3, phenomena not observed in ER-negative MDA-MB-231 cells. In conclusion, our results suggest that p-ser727-STAT3 may be involved in the pathogenesis of breast cancer in an ER-dependent manner.
    Relation: Int J Cancer. 118(12),2943-2947
    Appears in Collections:[醫學檢驗生物技術系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML819View/Open


    All items in FYIR are protected by copyright, with all rights reserved.


    本網站典藏內容為學術研究目的之提供,請尊重著作權人之權益合理使用,請勿任意重製、轉貼、改作及散佈。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback